Navigation Links
Velocity Pharmaceutical Development and Tigercat Pharma Inc. Announce Submission of IND Application for VPD-737
Date:8/19/2013

SOUTH SAN FRANCISCO, Calif., Aug. 19, 2013 /PRNewswire/ -- Velocity Pharmaceutical Development, LLC ("VPD") and Tigercat Pharma, Inc., ("Tigercat") announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) for VPD-737 for the treatment of chronic pruritus.

Tigercat licensed worldwide rights to VPD-737 (Serlopitant), an NK-1 receptor antagonist, from Merck (Essex Chemie) in 2012.  Tigercat intends to develop VPD-737 through clinical proof of concept for the treatment of chronic pruritus, defined as itch lasting for more than 6 weeks. This condition results in more than one million doctor visits per year in the US. Chronic pruritus is associated with significant morbidity and can result in serious disruption of sleep and other activities of daily living.

"Preclinical studies and compelling clinical evidence about the use of NK-1 receptor antagonists led us to believe that treatment with VPD-737 may significantly and rapidly reduce pruritus associated with a variety of conditions" said David Collier, CEO of VPD. "We believe this drug has the potential to address a major underappreciated medical need."

Jean Tang M.D., Ph.D., Professor of Dermatology at Stanford University School of Medicine said "Chronic itch is a largely underserved indication with few effective treatments.  The existing drugs to treat chronic itch are at best only modestly effective and in addition, they are poorly tolerated. Thus we are very excited to see VPD-737 approaching clinical testing."

About Tigercat Pharma, Inc.
Tigercat Pharma, Inc., is a largely "virtual" company which was created to hold the ownership of the VPD-737 development program.  Tigercat is funded by Velocity Pharmaceutical Holdings, LLC, and Remeditex Ventures, LLC.  The VPD-737 development program is managed
'/>"/>

SOURCE Velocity Pharmaceutical Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharmaceutical Cold Supply Chain and Green Logistics, a New Xtalks Life Sciences Webinar
2. Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results
3. Pharmaceutical Companies Announce Quarterly Financial Results - Research Report on Jazz, Acadia, Arena, Santarus, and Incyte
4. GW Pharmaceuticals to Present at the 33rd Annual Canaccord Genuity Growth Conference
5. James Mazzo Appointed Executive Chairman of Neurotech Pharmaceuticals
6. Flagship Biosciences Expands Digital Pathology with Pharmaceutical Biostatistics Services
7. India Pharmaceutical Sector Reviewed by Kelly Scientific Publications in In-demand Report Now Available at MarketPublishers.com
8. Gallus BioPharmaceuticals Enters Clinical Supply Agreement with Genzyme for Niemann-Pick Type B Disease
9. PolyTherics and Antitope Combine to Create Leading Provider of Solutions to Enable the Development of Better Biopharmaceuticals
10. RXi Pharmaceuticals Announces Application for NASDAQ Capital Market Listing and Reverse Stock Split
11. China Pharmaceutical Industry Examined in New Kelly Scientific Publications Report Available at MarketPublishers.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... orders to $5.8 million and provides a good start to Q4.  ... North America and one in the Middle ... at record levels," said Peter Bruijns , President & CEO. ... of Q3 than they have been for any complete year since ...
(Date:10/20/2014)... N.J. (PRWEB) October 20, 2014 ... the Sidney Kimmel Cancer Center at Thomas Jefferson ... , Through the Strategic Alliance Partnership program, ... OncLive will collaborate to raise awareness of the ... treatment, and other projects. Clinicians and other health ...
(Date:10/19/2014)... 20, 2014 OCTOBER 20-22, ... (ABIM). ABIM will take place at ... about ABIM 2014 is now available at ... representing companies and organizations from all over ... information on the latest products and developments ...
(Date:10/19/2014)... The Asia-Pacific Speech Analytics market report ... with analysis and forecast of revenue. This market is ... $208 million by 2019, at a Compound Annual Growth ... Browse through the TOC of the Asia-Pacific Speech Analytics ... analysis provided. It also provides a glimpse of the ...
Breaking Biology Technology:Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4
... 2012   Led by NUMODA CAPITAL INNOVATIONS, LLC., PINNACLE BIOLOGICS announced ... in a combination of Equity, and Debt Conversion. ... for Pinnacle Biologics. After completing the acquisition of ... Aptalis Pharma early last year, Pinnacle continues the ...
... Jan. 9, 2012 Exagen Diagnostics, Inc., ... and markets proprietary tests for rheumatologists and gastroenterologists, announced ... the diagnosis of lupus (Systemic Lupus Erythematosus). ... SLE and Rule-Out other rheumatic diseases to help establish ...
... Jan. 9, 2012 Chembio Diagnostics, Inc. (OTC.PK: ... and licenses point-of-care diagnostic tests, today announced that Lawrence ... at the Biotech Showcase in San Francisco at approximately ... Wednesday, January 11, 2012.   The conference ...
Cached Biology Technology:Pinnacle Biologics, Inc. Announces the Successful Completion of a Financing Round 2Pinnacle Biologics, Inc. Announces the Successful Completion of a Financing Round 3Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic 2Chembio Presenting at Biotech Conference 2Chembio Presenting at Biotech Conference 3
(Date:10/17/2014)... German . ... in order to reproduce? And why are there two sexes ... latest issue of the research journal Molecular Human Reproduction ... Ramm from Bielefeld University Bielefeld has compiled this special issue ... a female to copulate with several males in quick succession ...
(Date:10/16/2014)... and Washington land managers have a new synthesis of ... moist mixed-conifer (MMC) forests in the two states. ... in Eastern Oregon and Washington: A Synthesis of the ... a general technical report published by the U.S. Forest ... to a request from managers for a synthesis of ...
(Date:10/16/2014)... , October 16, 2014 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... edge technologies including Wocket™, the Smart Wallet, at the ... FiRe is a leading global conference on the intersection ... by Mark Anderson , founder and publisher of ...
Breaking Biology News(10 mins):Sperm wars 2New report synthesizes best available science on management of moist mixed-conifer forests 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
... MANHATTAN, Kan. -- What if you could shut down ... How about hacking a pacemaker and reprogramming it to ... scenes from an espionage film, they are also some ... experts are working to prevent. Eugene Vasserman, assistant ...
... cucumbers and other crops susceptible to infection by downy ... production costs thanks to collaborative research by Clemson University,s ... North Carolina State University. Anthony P. Keinath, professor ... Center in Charleston, recently was awarded a $40,000 USDA ...
... elk,s personality type is a big factor in whether or ... GPS collars on more than 100 male and female elk ... population could be divided into two categories: bold runners and ... moved quickly through the study area and preferred to graze ...
Cached Biology News:Internal relations 2Internal relations 3Internal relations 4Clemson plant pathologist working to raise cucurbit yields, lower production costs 2In elk hunting, success depends on the animal's personality 2
Cord blood endothelial progenitor cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Progenitor Cells...
Umbilical cord blood CD14+ Monocytes, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Human peripheral blood basophils, For immunohistochemistry (IHC) Cell Chip with Human Peripheral Blood Granulocytes...
Umbilical cord blood CD19+ B cells, For immunohistochemistry (IHC) Cell Chip with Human Umbilical Cord Blood Monocytes, B Cells and NK Cells...
Biology Products: